These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10116667)

  • 21. Effect of drug industry marketing practices on formularies questioned by federal agencies.
    Gatty B
    Hosp Formul; 1994 Nov; 29(11):786, 785. PubMed ID: 10138576
    [No Abstract]   [Full Text] [Related]  

  • 22. Label fables: EPA cites hype in 'bugproof' products.
    Blyth PL
    Health Facil Manage; 1998 Sep; 11(9):54, 56-7. PubMed ID: 10182769
    [No Abstract]   [Full Text] [Related]  

  • 23. Prescription drug advertising--should states regulate what is false and misleading?
    Shaeffer J
    Food Drug Law J; 2003; 58(4):629-48. PubMed ID: 15027454
    [No Abstract]   [Full Text] [Related]  

  • 24. List of drug products that have been withdrawn or removed from the market for reasons of safety or effectiveness--FDA. Proposed rule.
    Fed Regist; 1998 Oct; 63(195):54082-9. PubMed ID: 10185826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical evaluation of glutaraldehyde-phenate (Sporicidin) used to disinfect arthroscopes.
    Derby B; McGucken E
    Orthop Nurs; 1984; 3(5):36-8. PubMed ID: 6436775
    [No Abstract]   [Full Text] [Related]  

  • 26. Medical devices; reports of corrections and removals--FDA. Direct final rule.
    Fed Regist; 1998 Aug; 63(152):42229-33. PubMed ID: 10181725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medical devices; device tracking; new orders to manufacturers--FDA. Notice.
    Fed Regist; 1998 Mar; 63(42):10638-40. PubMed ID: 10177504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What you should know about FDA-USP Drug Product Problem Reporting Program.
    McGinnis DM
    Pharm Times; 1986 Apr; 52(4):101-4, 109. PubMed ID: 10276472
    [No Abstract]   [Full Text] [Related]  

  • 29. Form for reporting serious adverse events and product problems with human drug and biological products and devices; availability--FDA. Notice.
    Fed Regist; 1993 Jun; 58(105):31596-614. PubMed ID: 10171452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expedited safety reporting requirements for human drug and biological products; correction--FDA. Final rule; correction.
    Fed Regist; 1998 Mar; 63(58):14611-2. PubMed ID: 10177754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postmarketing studies for approved human drug and licensed biological products; status reports. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Oct; 65(210):64607-19. PubMed ID: 11503687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medical devices; reports of corrections and removals; companion to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 Aug; 63(152):42300-4. PubMed ID: 10181727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The unfinished business of U.S. drug safety regulation.
    Evans BJ; Flockhart DA
    Food Drug Law J; 2006; 61(1):45-63. PubMed ID: 16838457
    [No Abstract]   [Full Text] [Related]  

  • 34. Medical devices; device tracking--FDA. Final rule; notification of status under the Safe Medical Devices Act; confirmation of effective date.
    Fed Regist; 1992 May; 57(104):22966-70. PubMed ID: 10171013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FDA marketing claims, and the practitioner.
    Runner S
    J Evid Based Dent Pract; 2006 Mar; 6(1):19-23. PubMed ID: 17138391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FDA withholds approval of anti-infection drug; manufacturer's stock price plunges.
    Wagner M
    Mod Healthc; 1992 Apr; 22(16):6. PubMed ID: 10117563
    [No Abstract]   [Full Text] [Related]  

  • 37. Germ busters. Experts tell how to choose--and use--the best antimicrobials.
    Cokendolpher JC; Haukos JF
    Mater Manag Health Care; 1996 Apr; 5(4):42, 44, 46-9. PubMed ID: 10157556
    [No Abstract]   [Full Text] [Related]  

  • 38. Reporting device-related problems and incidences to the FDA.
    Vlchek DL; Burrows-Hudson S
    Nephrol News Issues; 1990 Oct; 4(10):32, 39. PubMed ID: 2234123
    [No Abstract]   [Full Text] [Related]  

  • 39. Reporting drug product defects--JCAHO.
    Hoffmann RP
    Hosp Pharm; 1989 Feb; 24(2):143-4. PubMed ID: 10318199
    [No Abstract]   [Full Text] [Related]  

  • 40. Blowing the whistle at the FDA.
    Simons J
    Fortune; 2005 Jan; 151(2):32. PubMed ID: 15693304
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.